The role of the emergency department in acute heart failure clinical trials-Enriching patient identification and enrollment

American Heart Journal

Volumn 165, Issue 6, 2013, Pages 902-909

  Collins, Sean P ^a   Levy, Phillip D ^b   Pang, Peter S ^c   Gheorghiade, Mihai ^c  

^a VANDERBILT UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; TROPONIN; VASODILATOR AGENT;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); DIFFERENTIAL DIAGNOSIS; DYSPNEA; EARLY INTERVENTION; ELECTROCARDIOGRAM; EMERGENCY PHYSICIAN; EMERGENCY WARD; HEART INFARCTION; HEMODYNAMICS; HUMAN; HYPERTENSIVE CRISIS; HYPONATREMIA; KIDNEY DYSFUNCTION; LUNG EDEMA; MEDICAL DECISION MAKING; NONINVASIVE VENTILATION; OBSERVATION UNIT; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RESUSCITATION; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX RADIOGRAPHY;

EID: 84880078759     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.03.009     Document Type: Review

References (35)

1. Fonarow GC. The Acute Decompensated Heart Failure National Registry (ADHERE): Opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 2003;4(Suppl 7):S21-30.
2. Mebazaa A, Pang PS, Tavares M, et al. The impact of early standard therapy on dyspnoea in patients with acute heart failure: The URGENT-dyspnoea study. Eur Heart J 2010;31:832-41.
3. Maisel AS, Peacock WF, McMullin N, et al. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: An ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol 2008;52: 534-40.
4. Weintraub NL, Collins SP, Pang PS, et al. Acute heart failure syndromes: Emergency department presentation, treatment, and disposition: Current approaches and future aims: A scientific statement from the American Heart Association. Circulation 2010;122:1975-96.
5. Wang CS, FitzGerald JM, Schulzer M, et al. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA 2005;294:1944-56.
6. Fonarow GC, Abraham WT, Albert NM, et al. Day of admission and clinical outcomes for patients hospitalized for heart failure: Findings from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Circ Heart Fail 2008;1:50-7.
7. Fonarow GC, Stough WG, Abraham WT, et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: A report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 2007;50:768-77.
8. Yancy CW, Lopatin M, Stevenson LW, et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: A report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006;47:76-84.
9. Committee ASA. In: Scios I, editor. Acute Decompensated Heart Failure National Registry(ADHERE®) Core Module Q1 2006 Final Cumulative National Benchmark Report; 2006.
10. Amin A. Who is managing acute decompensated heart failure? The need for a multidisciplinary approach. J Hosp Med 2008;3:S1-6.
11. Roytman MM, Thomas SM, Jiang CS. Comparison of practice patterns of hospitalists and community physicians in the care of patients with congestive heart failure. J Hosp Med 2008;3: 35-41.
12. Felker GM, Pang PS, Adams KF, et al. Clinical trials of pharmacological therapies in acute heart failure syndromes: Lessons learned and directions forward. Circ Heart Fail 2010;3:314-25.
13. Storrow AB, Jenkins C, Collins SP, et al. Emergency department disposition and charges for heart failure: Regional variability. Society for Academic Emergency Medicine, Chicago, IL; 2012.
14. Peacock WF, Fonarow GC, Emerman CL, et al. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE. Cardiology 2007;107:44-51.
15. Peacock WF, Emerman C, Costanzo MR, et al. Early vasoactive drugs improve heart failure outcomes. Congest Heart Fail 2009;15: 256-64.
16. Pang PS, Gheorghiade M, Dihu J, et al. Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: Analysis from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) trials. Am Heart J 2011;161:1067-72.
17. Pang PS, Konstam MA, Krasa HB, et al. Effects of tolvaptan on dyspnoea relief from the EVEREST trials. Eur Heart J 2009;30: 2233-40.
18. O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365:32-43.
19. Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006;296: 2217-26.
20. Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 2010; 16: E1-194.
21. Teerlink JR, Cotter G, Davison BA, et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): A randomised, placebo-controlled trial. Lancet 2013;381(9860):29-39.
22. Gheorghiade M, Gattis WA, O'Connor CM, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: A randomized controlled trial. JAMA 2004; 291:1963-71.
23. Butler J, Subacius H, Vaduganathan M, et al. Relationship Between Clinical Trial Site Enrollment With Participant Characteristics, Protocol Completion, and Outcomes: Insights From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Trial. J Am Coll Cardiol 2013;61(5):571-9.
24. Gheorghiade M, Vaduganathan M, Greene SJ, et al. Site selection in global clinical trials in patients hospitalized for heart failure: Perceived problems and potential solutions. Heart Fail Rev 2012.
25. Peacock WF, Chandra A, Collins SP, et al. Clevidipine improves dyspnea in emergency department acute heart failure: A randomized, open label study. Los Angeles (Calif): American Heart Association; 2012.
26. Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012;366:591-600.
27. Aufderheide TP, Nichol G, Rea TD, et al. A trial of an impedance threshold device in out-of-hospital cardiac arrest. N Engl J Med 2011;365:798-806.
28. Kuppermann N, Holmes JF, Dayan PS, et al. Identification of children at very low risk of clinically-important brain injuries after head trauma: A prospective cohort study. Lancet 2009;374:1160-70.
29. Idris AH, Guffey D, Aufderheide TP, et al. Relationship between chest compression rates and outcomes from cardiac arrest. Circulation 2012;125:3004-12.
30. Corneli HM, Zorc JJ, Mahajan P, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 2007;357:331-9.
31. Teerlink JR, Metra M, Felker GM, et al. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): A multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 2009;373:1429-39.
32. Picano E, Frassi F, Agricola E, et al. Ultrasound lung comets: A clinically useful sign of extravascular lung water. J Am Soc Echocardiogr 2006;19:356-63.
33. Collins S, Storrow AB, Kirk JD, et al. Beyond pulmonary edema: Diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department. Ann Emerg Med 2008;51:45-57.
34. Collins SP, Lindsell CJ, Pang PS, et al. Bayesian adaptive trial design in acute heart failure syndromes: Moving beyond the mega trial. Am Heart J 2012;164:138-45.
35. Peacock WF, Braunwald E, Abraham W, et al. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: Research challenges and opportunities. J Am Coll Cardiol 2010;56:343-51.